Concepedia

Ty Brender

TB

9

Publications

1.7K

Citations

9

H-Index

2001

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

HistoGenetics (United States)

Institute for In Vitro Sciences

Ty Brender is an author at Bristol-Myers Squibb (United States) specializing in immunology, medicine, and immunotherapy.

Top concepts

Publications per year

2001–2020

9

Publications

9

Interleukin 20

Hal Blumberg, Darrell Conklin, Wenfeng Xu et al. · Cell · 2001 · 546 citations · Full text

Identification of the IL-17 Receptor Related Molecule IL-17RC as the Receptor for IL-17F

Rolf Kuestner, David W. Taft, Aaron C. Haran et al. · The Journal of Immunology · 2007 · 352 citations · Full text

, , +12

Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes

Julia Parrish-Novak, Wenfeng Xu, Ty Brender et al. · Journal of Biological Chemistry · 2002 · 267 citations · Full text

A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist

Wenfeng Xu, Scott Presnell, Julia Parrish-Novak et al. · Proceedings of the National Academy of Sciences · 2001 · 213 citations · Full text

, , +15

Mapping the Energetic Epitope of an Antibody/Interleukin-23 Interaction with Hydrogen/Deuterium Exchange, Fast Photochemical Oxidation of Proteins Mass Spectrometry, and Alanine Shave Mutagenesis

Jing Li, Hui Wei, Stanley R. Krystek et al. · Analytical Chemistry · 2017 · 83 citations · Full text

, , +20

Rows per page

1–5 of 9